Cambridge, MA, United States of America

Nasa Sinnott-armstrong

This inventor holds 1 USPTO granted patent. Top assignee: The Broad Institute, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nasa Sinnott-armstrong. Retrieved from https://idiyas.com/inventor/nasa-sinnott-armstrong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nasa Sinnott-Armstrong: Innovator in Metabolic Disorder Treatments

Introduction

Nasa Sinnott-Armstrong is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of metabolic disorders through his innovative research and patent.

Latest Patents

Nasa holds a patent titled "Methods for Treating Metabolic Disorders by Targeting ADCY5." This patent represents his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Nasa Sinnott-Armstrong is affiliated with The Broad Institute, Inc., where he works alongside other talented researchers. His work focuses on understanding and treating metabolic disorders, showcasing his dedication to scientific advancement.

Collaborations

He collaborates with esteemed colleagues, including Melina Claussnitzer and Isabel Sousa. These partnerships enhance the research environment and contribute to innovative solutions in the field.

Conclusion

Nasa Sinnott-Armstrong is a key figure in the development of treatments for metabolic disorders, with a notable patent and a strong collaborative network. His work continues to impact the scientific community and improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…